Bethesda, United States
Epidarex Capital (formerly Rock Spring Ventures) invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and US. Epidarex funds the commercialization of ground-breaking research and new technologies to address large and unmet needs in today's healthcare market.
34
Total Investments
18
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Epidarex Capital
Recent Investments (34)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Aug 2026 | |
| Venture Round | •••••• | Jan 2025 | |
| Venture Round | •••••• | Apr 2024 | |
| Series A | •••••• | Feb 2024 | |
| Series B | •••••• | Jan 2024 | |
•••• ••••
|
Series A | •••••• | Sep 2023 |
|
•••• ••••
|
Series A | •••••• | Nov 2022 |
|
•••• ••••
|
Seed Round | •••••• | May 2022 |
|
•••• ••••
|
Grant | •••••• | Apr 2022 |
|
•••• ••••
|
Series B | •••••• | Mar 2022 |
Latest News
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment
Eu-startups · Aug 07, 2026
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
